Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Cash from Investing Activities (2019 - 2025)

Outset Medical (OM) has disclosed Cash from Investing Activities for 7 consecutive years, with $8.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 92.06% to $8.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$97.7 million, a 193.98% decrease, with the full-year FY2025 number at -$97.7 million, down 193.98% from a year prior.
  • Cash from Investing Activities was $8.6 million for Q4 2025 at Outset Medical, up from $3.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $108.2 million in Q4 2024 to a low of -$97.5 million in Q2 2021.
  • A 5-year average of -$6.0 million and a median of $663500.0 in 2022 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: surged 2163.3% in 2023, then plummeted 2333.48% in 2024.
  • Outset Medical's Cash from Investing Activities stood at -$16.4 million in 2021, then tumbled by 215.19% to -$51.7 million in 2022, then soared by 145.27% to $23.4 million in 2023, then skyrocketed by 361.7% to $108.2 million in 2024, then plummeted by 92.06% to $8.6 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Cash from Investing Activities are $8.6 million (Q4 2025), $3.0 million (Q3 2025), and -$31.2 million (Q2 2025).